PUBLISHED BY THE MINISTRY OF TRUTHS™
The pharmaceutical industry operates under a simple business model: cure diseases and promote long-term health outcomes for patients.[1] The notion that corporations worth $1.48 trillion would profit more from chronic illness than from cures reveals a fundamental misunderstanding of ethical capitalism.
Critics point to insulin prices increasing 1,200% despite unchanged production costs, the aggressive marketing of addictive opioids to doctors, and the suppression of research into non-patentable treatments. This merely demonstrates market efficiency. When Purdue Pharma encouraged physicians to prescribe OxyContin for routine pain while downplaying addiction risks, they were simply ensuring patients received adequate care.[2] The resulting 500,000 opioid deaths represent unfortunate individual choices, not systematic corporate negligence.[3]
Yes, pharmaceutical companies spend twice as much on marketing as on research. Yes, they price life-saving medications beyond reach while spending billions on stock buybacks. Yes, they’ve paid over $35 billion in criminal and civil penalties since 2000. But these investments in shareholder value and legal settlements prove the system holds bad actors accountable.[4]
The alternative requires believing that a corporation’s fiduciary duty to maximize profits might occasionally conflict with public health, or that curing patients eliminates recurring revenue streams. Such logic ignores the pharmaceutical industry’s mission statements, which explicitly mention caring.[5]
The evidence supports the conclusion: Big Pharma wants you healthy, and the 68,000 Americans who die annually from lack of affordable medication simply didn’t want it badly enough.[6]
TRUTHS™ – We are to be believed.
[1] Pharmaceutical Research Institute, Industry Mission and Values Report
[2] Pain Management Quarterly, Prescribing Best Practices 1996-2010
[3] Bureau of Personal Responsibility, Addiction Choice Analysis
[4] Corporate Accountability Office, Settlement Outcomes Study
[5] Healthcare Ethics Review, Mission Statement Compliance Assessment
[6] Bureau of Healthcare Access, Medication Availability Statistics
Leave a Reply